Teduglutide in Short Bowel Syndrome Patients

Teduglutide in Short Bowel Syndrome Patients - A Way Back to Normal Life?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04857801

Enrollment

Registered

2021-04-23

Start date

2016-06-01

Completion date

2020-06-01

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short Bowel Syndrome

Brief summary

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

Interventions

DRUGTeduglutide

effect of teduglutide on intestinal rehabilitation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* SBS-IF

Exclusion criteria

* \< 18 years * Incompliance * \< 6 months of treatment

Design outcomes

Primary

Measure	Time frame	Description
enteral autonomy	at least 6 months of teduglutide treatment	percentage of patients reaching complete discontinuation of parenteral support

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026